Evidence map›Paper›PMID 40697996›Full record

ArticleFrontiers in cardiovascular medicine2025

Prognostic value of the ratio between right ventricular free wall longitudinal strain and systolic pulmonary artery pressure in patients with heart failure with reduced ejection fraction and ventricular secondary mitral regurgitation.

Călin-Dinu Hădăreanu, Diana-Ruxandra Hădăreanu, Despina-Manuela Toader, Maria-Livia Iovănescu, Cristina Florescu, Victor-Cornel Raicea, Ionuț Donoiu

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Prognostic Value of the RVFWLS/PASP Ratio in Pulmonary Arterial Hypertension.Journal of cardiovascular development and disease · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Călin-Dinu HădăreanuDoctoral School, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Diana-Ruxandra HădăreanuDepartment of Cardiology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Despina-Manuela ToaderDepartment of Cardiology, Clinical Emergency County Hospital of Craiova, Craiova, Romania.
Maria-Livia IovănescuDepartment of Cardiology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Cristina FlorescuDepartment of Cardiology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Victor-Cornel RaiceaDepartment of Cardiovascular Surgery, Clinical Emergency County Hospital of Craiova, Craiova, Romania.
Ionuț DonoiuDepartment of Cardiology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In heart failure (HF) with reduced ejection fraction (HFrEF), ventricular secondary mitral regurgitation (V-sMR) leads to progressive impairment of right ventricular (RV) function and adversely affects outcomes. Non-invasive indices of RV-pulmonary artery (RVPA) coupling may offer enhanced prognostic value. Methods: We retrospectively evaluated advanced echocardiographic surrogates of RVPA coupling in 104 HFrEF patients with V-sMR. Results: Over a median follow-up of 526 days, 48 patients (46.2%) reached the composite endpoint of rehospitalization for HF decompensation or all-cause mortality. Patients who experienced events had significantly larger RV volumes, lower RV functional indices, and higher systolic pulmonary artery pressure (sPAP) compared with those without events. Among the RVPA coupling measures, the ratio of RV free-wall longitudinal strain (RVFWLS) to sPAP had the highest predictive accuracy (area under the curve 0.730), with an optimal cut-off of 0.46%/mmHg (71% sensitivity, 69% specificity). Kaplan-Meier analysis showed significantly lower event-free survival for patients with RVFWLS/sPAP < 0.46%/mmHg (log-rank Conclusion: The RVFWLS/sPAP ratio, with a cut-off value of 0.46%/mmHg, is a robust, independent prognostic marker in HFrEF patients with V-sMR.

Indexed as

heart failure with reduced ejection fractionprognosisright ventricular strain to pulmonary artery pressureright ventricular to pulmonary artery couplingspeckle-tracking echocardiographythree-dimensional echocardiographyventricular secondary mitral regurgitation

Identifiers

PMID40697996
PMCPMC12279854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.